We ensure that products manufactured and distributed by us, consistently meet predetermined quality specifications and our customer expectations. We believe in continual improvement of our products and processes through training and innovation.
Shalina Kenya has registered a number of essential medicines with the MOH, across a range of therapeutic categories, including anti-infectives, anthelmintics and analgesics. Additionally, we have a significant pipeline of products under registration.
Our manufacturing plant in India has been approved by the Pharmacy and Poison Board of Kenya (PPB). Our team works across Kenya to promote our medicines and deliver continuous medical education. We distribute our pharmaceutical products across Kenya through our own distribution network.
Shalina Healthcare has recently acquired the brands of one of the leading pharmaceutical companies in Kenya – Pharmaceutical Manufacturing Company (PMC). The brands acquired from PMC will help Shalina to further serve the Kenya market and expand our reach in Eastern African. PMC brands have a strong equity in Kenya developed over decades and have a leadership position in their various therapeutic area. Some of the brands acquired are Clozole B , Pharmasal and Betason.
Please contact our Shalina Kenya Team at Kenya@shalina.com
- Full name: The Republic of Kenya
- Population: 52,257,562 (UN 2019)
- Capital: Nairobi
- Area: 580,367 km, (224,081 sq mi)
- Major languages: Swahili, English
- Major religion: Christianity
- Monetary unit: Kenyan shilling
- Main exports: Coffee, tea, spices, plants, vegetables
- GNI per capita: US $1,620 (World Bank, 2011)